Lead sponsor
Sykehuset Innlandet HF
3 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
3
Trials led
0
Ongoing
273
Total enrollment
8
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 3
1
Phase 4
2
Trials by status
Completed
3
Trials led
TrialEligibility highlightPhaseStatusEnrollment
The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD)Multiple dementia etiologiesPh 3Completed100
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSDMultiple dementia etiologiesPh 4Completed24